The rise in incidence of cardiovascular diseases such as heart attack, stroke, and coronary block artery, to boost the expansion of the global angiography devices market. The outbreak of the COVID-19 had a negative impact on the growth of the global market, owing to postponement of surgeries in cardiac patients during the COVID-19 pandemic. Based on region, the market across the Asia-Pacific region held the major market share in 2021.
The global angiography devices market generated $8.8 billion in 2021, and is projected to reach $15.9 billion by 2031, growing at a CAGR of 6% from 2022 to 2031.
Restraints:
Lack of skilled professional, poor reimbursement policies, and high cost of angiography devices
Drivers:
Rise in occurrence of cardiovascular disorders such as heart attacks and atherosclerosis disease.
Opportunities:
Increase in demand for minimally invasive procedures.
COVID-19 Scenario:
- The outbreak of the COVID-19 had a negative impact on the growth of the global angiography devices market, owing to the postponement of surgeries in cardiac patients during the COVID-19 pandemic.
- Moreover, non-essential surgeries took a potential backlog due to rapid increase in the number of COVID-19 patients, thereby severely impeding the growth of the global market.
Based on technology, the X-ray angiography segment held the major market share in 2021, holding more than half of the global angiography devices market share, and is expected to maintain its leadership status during the forecast period. Moreover, the same segment is expected to cite the fastest CAGR of 6.4% during the forecast period.
Based on application, the diagnostic segment held the major market share in 2021, contributing nearly three-fifths of the global angiography devices market share, and is expected to maintain its leadership position during the forecast period. Moreover, the same segment is expected to cite the highest CAGR of 6.3% during the forecast period.
The key players analyzed in the global angiography devices market report include Abbott Laboratories, Angiodynamics, Inc., Boston Scientific Corporation, B. Braun Melsungen AG, General Electric Company, Koninklijke Philips N.V., Medtronic Inc., Merit Medical Systems, Inc., Siemens Healthcare Gmbh, and Shimadzu Corporation.
The report analyzes these key players in the global angiography devices market. These market players have made effective use of strategies such as joint ventures, collaborations, expansion, new product launches, partnerships, and others to maximize their foothold and prowess in the industry. The report is helpful in analyzing recent developments, product portfolio, business performance, and operating segments by prominent players in the market.
0 Comments